CFO4Life’s Gilead Sciences GILD Stock Holding History

CFO4Life’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$968K	Buy	+11,270	New	+$892K	0.21%	64
2016 Q4	$792K	Buy	11,060 +1,611	+17%	+$120K	0.65%	22
2016 Q3	$748K	Sell	9,449 -5,914	-38%	-$480K	0.65%	23
2016 Q2	$1.28M	Buy	15,363 +660	+4%	+$58.6K	1.1%	17
2016 Q1	$1.35M	Sell	14,703 -2,396	-14%	-$216K	1.21%	16
2015 Q4	$1.73M	Buy	17,099 +2,722	+19%	+$283K	1.64%	14
2015 Q3	$1.41M	Buy	14,377 +464	+3%	+$51.5K	1.5%	13
2015 Q2	$1.63M	Buy	13,913 +540	+4%	+$59K	1.36%	16
2015 Q1	$1.31M	Buy	13,373 +1,484	+12%	+$151K	1.09%	20
2014 Q4	$1.12M	Buy	+11,889	New	+$1.23M	0.93%	16

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CFO4Life's GILD Position: Q4 2022 in Review

CFO4Life opened a new position in Gilead Sciences (GILD) in Q4 2022: 11,270 shares worth $968K. The stake represents 0.21% of the portfolio and ranks #64 among its holdings. This is a return to the name: CFO4Life previously reported a position in GILD as recently as Q4 2016.

CFO4Life first reported a position in GILD in Q4 2014 and has held it in 10 quarters since. The position peaked at $1.73M in Q4 2015. 1,768 funds tracked by Wall St. Rank hold GILD as of Q4 2022.

CFO4Life held 11,270 shares of Gilead Sciences worth $968K as of Q4 2022.
Gilead Sciences was a new CFO4Life position in Q4 2022.
Gilead Sciences made up 0.21% of CFO4Life's portfolio in Q4 2022, its #64 holding.
CFO4Life first reported a position in Gilead Sciences in Q4 2014 and has held it in 10 quarters since.
CFO4Life's Gilead Sciences position peaked at $1.73M in Q4 2015.
1,768 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2022.

Based on CFO4Life's 13F filing for Q4 2022, filed 11 Jan 2023.